Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)
CUSIP: 45258J102
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 202,731,676
- Total 13F shares
- 12,628,676
- Share change
- +1,297,144
- Total reported value
- $193,544,419
- Price per share
- $15.56
- Number of holders
- 40
- Value change
- +$19,992,364
- Number of buys
- 29
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45258J102:
Top shareholders of IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
2.2%
|
4,426,106
|
$66,048,000 | — | 31 Dec 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.5%
|
1,020,000
|
$16,187,000 | — | 31 Dec 2019 | |
| BVF INC/IL |
13F
|
Company |
0.49%
|
999,996
|
$15,850,000 | — | 31 Dec 2019 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.39%
|
800,000
|
$12,696,000 | — | 31 Dec 2019 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.31%
|
621,505
|
$9,851,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.3%
|
599,867
|
$9,520,000 | — | 31 Dec 2019 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.25%
|
504,117
|
$8,000,000 | — | 31 Dec 2019 | |
| Athanor Capital, LP |
13F
|
Company |
0.25%
|
500,000
|
$7,935,000 | — | 31 Dec 2019 | |
| Polar Capital LLP |
13F
|
Company |
0.19%
|
393,750
|
$6,249,000 | — | 31 Dec 2019 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.3%
|
615,400
|
$5,483,000 | — | 31 Dec 2019 | |
| Woodline Partners LP |
13F
|
Company |
0.13%
|
272,539
|
$4,320,000 | — | 31 Dec 2019 | |
| Prosight Management, LP |
13F
|
Company |
0.11%
|
224,702
|
$3,566,000 | — | 31 Dec 2019 | |
| Granite Point Capital Management, L.P. |
13F
|
Company |
0.11%
|
220,000
|
$3,491,000 | — | 31 Dec 2019 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
0.05%
|
100,000
|
$1,587,000 | — | 31 Dec 2019 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.04%
|
85,000
|
$1,349,000 | — | 31 Dec 2019 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
84,663
|
$1,344,000 | — | 31 Dec 2019 | |
| Eversept Partners, LP |
13F
|
Company |
0.04%
|
76,866
|
$1,219,863 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
23,574
|
$374,000 | — | 31 Dec 2019 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.01%
|
21,800
|
$346,000 | — | 31 Dec 2019 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.01%
|
20,000
|
$317,000 | — | 31 Dec 2019 | |
| PA Capital LLC |
13F
|
Company |
0.01%
|
13,871
|
$220,000 | — | 31 Dec 2019 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.01%
|
13,400
|
$213,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,076
|
$17,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,000
|
$16,000 | — | 31 Dec 2019 |
Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q1 2020
As of 31 Mar 2020,
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,628,676 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., BVF INC/IL, BlackRock Inc., Ikarian Capital, LLC, Ghost Tree Capital, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, MANGROVE PARTNERS, MILLENNIUM MANAGEMENT LLC, and Polar Capital LLP.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
24
Q1 2020 holders
40
Holder diff
16
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.